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Abstract
A priori registration of randomized clinical trials is crucial to the transparency and credibility
of their findings. Aim of this study was to assess the frequency with which registered and
completed randomized trials in orthodontics are published. We searched ClinicalTrials.gov
and ISRCTN for registered randomized clinical trials in orthodontics that had been com-
pleted up to January 2017 and judged the publication status and date of registered trials
using a systematic protocol. Statistical analysis included descriptive statistics, chi-square or
Fisher exact tests, and Kaplan-Meier survival estimates. From the 266 orthodontic trials reg-
istered up to January 2017, 80 trials had been completed and included in the present study.
Among these 80 included trials, the majority (76%) were registered retrospectively, while
only 33 (41%) were published at the time. The median time from completion to publication
was 20.1 months (interquartile range: 9.1 to 31.6 months), while survival analysis indicated
that less than 10% of the trials were published after 5 years from their completion. Finally,
22 (28%) of completed trials remain unpublished even after 5 years from their completion.
Publication rates of registered randomized trials in orthodontics remained low, even 5 years
after their completion date.
Introduction
Randomized clinical trials are the gold standard in comparative effectiveness research, due to
their explicit methods, internal validity, and transparency. Crucial to this transparency is the
provision of an a priori designed protocol that delineates each trial aspect. This can also be
used to compare the original trial plan with its subsequent publication [1] to ascertain the tri-
al’s original scope, as well as minimize the risk of data dredging. Furthermore, a priori registra-
tion of clinical trials can safeguard against dangers like delayed publication or non-publication
of trials, selective reporting of outcomes, per protocol rather than intention-to-treat analyses,
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and trial overlaps among papers included within systematic reviews [1–4]. Such a priori regis-
tered trial protocols can be either published as standalone publications [5] and/or be registered
in freely accessible online repositories [6].
One such freely accessible online repository is ClinicalTrials.gov (https://clinicaltrials.gov/),
a trial registry and results database maintained by the US National Library of Medicine.
Although there is no formal requirement that all funded trials must be registered in Clinical-
Trials.gov, the International Committee of Medical Journal Editors (ICMJE) began from 2005
requiring trial registration as a prerequisite for publication in any of its member journals [7].
This led to a considerable increase of trials being registered, which now reach several hundreds
of new trials being registered each week [8]. Another well-known registry for clinical trials in
medicine is the International Standard Randomised Controlled Trial Number (ISRCTN) reg-
istry (http://www.isrctn.com/), which contains the basic set of data items deemed essential to
describe a study at inception, as per the requirements set out by the World Health Organiza-
tion, the International Clinical Trials Registry Platform, and the ICMJE guidelines. These two
registries represent the two major recipients of trial registrations worldwide [8], while all trial
records in these databases are freely accessible and have been assigned a unique trial identifier,
thereby enabling linking trial registrations to their subsequent publications.
However, existing research shows that the results of studies are often not shared publicly in
a timely way and that between 25% and 50% of clinical trials remain unpublished even several
years after completion [9–11]. There are many possible reasons behind the delayed or non-
publication of results from clinical trials, including lack of incentive to disseminate negative
findings, time constraints, limited resources, changing research interests, or even failure to
have an article accepted by a journal. Importantly, time-lags in the dissemination of results
may have adverse consequences for the practice of evidence based medicine and for public
health [12]. The non-publication of trial results also violates an ethical obligation that trial
investigators have towards trial participants [13]. Even if trials do eventually get published
years later, it may be too late, and the results may have less relevance because of the rapid
changes in the landscape of evidence.
Although several studies have estimated the proportion of incomplete or selective reporting
in various medical specialties [14–17], no such assessments exist in orthodontics. A previous
study [18] provided an overview of registered trials in orthodontics up to 2014, but was limited
to descriptive analysis of their registrations and did not assess which were eventually pub-
lished. Aim of the present study was to assess the publication fate of registered orthodontic
randomized clinical trials and to assess characteristics related to their publication timing.
Materials and methods
Study sample
The protocol for the present study was drafted prior to study initiation, but was not registered
in PROSPERO, as it did not meet PROSPERO’s prerequisite of having clinical connection to
the trials’ results. For this study two authors (SNP and GNA) searched independently two
online registries for randomized trials, ClinicalTrials.gov and ISRCTN, up to January 2017. As
we intended to assess the publication fate of these trials, only registrations of trials marked in
the registries as completed were included. Registrations of non-randomized or non-orthodon-
tic trials were excluded, while any registrations pertaining to the same trial were grouped
together.
The same two authors (SNP and GNA) subsequently searched independently in January
2017 for any publications originating from the completed registered trials using a previous
comprehensive locating protocol [19]. Initially, the publication field of the trial protocol
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registration was searched for any linked references. Secondly, the unique trial identifier
assigned within each registration was used to search the web through Google (https://www.
google.com), Google Scholar (https://scholar.google.com/), and MEDLINE via Pubmed
(https://www.ncbi.nlm.nih.gov/pubmed/). Finally, if no corresponding publications could be
traced, the names of all investigators listed in the trial protocol as principal investigator or oth-
erwise were used for searches in MEDLINE, combining them with the keyword orthodon
(Table A in S1 File). Manually-identified publications were judged as originating from a spe-
cific trial registration, if either (i) the unique registration identifier was reported within the
trial publication or (ii) the used author names overlapped between protocol and publication,
the trial was randomized and on the same subject as the protocol, and patient enrollment in
the publication matched the trial protocol description. Only publications from scientific jour-
nals were included, while trial publications in the form of theses/dissertations were excluded,
as they follow considerably different publication pathways and are not subject to the same peer
review procedures as journal papers. The trial’s Pubmed Unique Identifier (PMID) (or manual
unique identifiers in case that didn’t exist) was assigned to each identified trial publication for
identification purposes.
Data extraction
The same two authors (SNP and GNA) independently extracted data on the level of trial regis-
tration and trial publication, using pre-defined and calibrated extraction forms. Extracted data
from the trial’s registration included registry, registration number, clinal setting (university
clinic, hospital, or private practice), geographic information (country and continent), trial
start- and end-date, sponsor (internal, government, commercial, or other), registration’s tim-
ing (registered before or after trial initiation [20]), trial nature (single-center of multicenter),
outcome type (patient-reported or investigator-assessed), age of eligible patients (children,
adults, or mixed), and trial size (arbitrarily categorized as or < 100 patients per trial arm
based on empirical data [21]). Extracted data from the trial’s publication included, PMID, pub-
lication date, number of identified publications from the same trial, journal name, journal
publication type (with or without electronic publication ahead of print), and trial findings
(judged from the abstract as positive, not positive, or unclear). Information about the affilia-
tion and geographical location of a trial was based on the person listed as principal investigator
of each trial or the responsible party, if no principal investigator was listed. We measured the
time from trial completion to publication by calculating the duration of time (in months). The
trial completion date was determined from the trial’s registration, while the earliest date a trial
emerged in MEDLINE was adopted as its publication date. For two trials that were not listed
in MEDLINE publication date was the first day of the journal publication issue’s month. If a
trial publication pertained to preliminary results of a trial and not the final results of the trial’s
primary outcome, the trial was coded as unpublished. For all trials without any identified pub-
lications we calculated the follow-up time as the duration in months between trial completion
and end date of our study (January 12, 2017).
Statistical analysis
We conducted a descriptive analysis calculating frequencies for binary outcomes or medians,
Interquartile Ranges (IQRs), and ranges for continuous outcomes, due to skewness of the
latter. Simple differences in the trial publication rate and completion-to-publication time
according to the various descriptive characteristics were investigated with chi-square /Fisher
exact and Kruskal-Wallis tests, respectively. For the analyses, geographic regions (continent)
were merged together, if less than 10 trials to avoid data thinning. In addition, we evaluated
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publication fate of included registered trials using Kaplan-Meier analysis after checking for
assumptions and assessed influencing factors with graphical inspection and log-rank tests.
For the survival analyses the completion-to-publication time for published trials (or the com-
pletion-to-January 2017 time for unpublished trials) were used as follow-up periods, while all
trials that remained unpublished were censored. All analyses of data (S1 Dataset) were per-
formed in Stata version SE 14 (StataCorp LP, College Station, TX) with a level of significance
set at 5%.
Results
We identified a total of 266 registered trials in orthodontic, 130 of which were completed in
January 2017, and were assessed for eligibility in the present study (Fig 1; Table B in S1 File).
Finally, a total of 50 registered trials were judged as ineligible, leaving 80 registered trials that
were finally included in this study. These pertained to 80 randomized trials, the majority
(59%) of which originated from Europe and specifically from the United Kingdom (44%).
They were initiated between 1997–2015 and were completed between 2003–2016 (Table 1).
From the identified trials, half of them (50%) had no external financial support, while only
the minority (8%) included multiple trial sites (Table 2). The median number of planned
patients to be enrolled in the trial was 50 patients (IQR: 30–90 patients; Table 3), while only
23% of the trials had a large sample size ( 100 patients). Interestingly, only 24% of trial proto-
cols were registered prospectively and the vast majority of trials (76%) were registered after
trial initiation.
As far as publication fate of the registered trials is concerned, only 33 (41%) of the 80 identi-
fied completed trials including at least 3839 patients had been published in journals at the time
this study was completed, with 10% of trials being published in multiple papers (Table 2). The
majority of registered trials were published in specialty journals and in journals that provided
electronic publication ahead of print option (64% and 55% respectively). Finally, about equal
parts of the 33 published trials reported positive and non-positive findings (42% and 45%,
respectively), while results were inconclusive in the remaining 4 trials (12%). No association
between publication rate and characteristics of the registered trials could be found (Table 3).
The single exception was the geographic location of the trial, with registered trials from North
America and Africa being published less often than trials from other continents. However,
the remaining 47 (59%) registered and completed trials, including at least 2355 randomized
patients, remained unpublished at the time of the present study.
Among the 33 completed trials that were eventually published, 10 (30%), 18 (55%), 27
(82%), 29 (88%), and 30 (91%) of them were published within 12, 24, 36, 48, and 60 months
after trial completion, respectively (Table 2). The median time from completion to publication
was 20.1 months with an IQR of 9.1–31.6 months) (Table 4). Considerable differences in the
completion-to-publication time were found according to registry, sponsor type, patient age,
and journal (Table C in S1 File), with trials from ClinicalTrials.gov, internally sponsored, with
adult or mixed patient populations, and trials submitted in non-specialty journals were pub-
lished faster than the rest.
The Kaplan-Meier estimates of the publication fate for the 80 included trials indicated that
most of them were published during the first 24 or 48 months after completion (Figure A in S2
File). On the other side, about 60 months (five years) after completion no considerable publi-
cation activity was seen. Differences in the survival curves can be seen in Figures B-M in S2
File. Trials registered in ClinicalTrials.gov seemed to be published faster and more often than
trials registered in ISRCTN (Figure B in S2 File), while considerable differences in the publica-
tion fate were seen across continents (Figure E in S2 File). Additionally, trials with adult
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patients or trials with unspecified patient populations seemed to be published less or more
slowly than trials on children (Figure I in S2 File). Finally, among the 33 published trials, trials
in non-specialty journals seemed to get published faster than trial publications in specialty
journals (Figure K in S2 File).
As the majority (30 out of 33 trials; 91%) of completed and published trials were published
within 5 years from their completion (Table 2), a free-period of 5 years from completion was
allowed for all 80 identified and completed trials. However, about one third (n = 22; 28%) of
completed trials still remained unpublished, even though 5 years had elapsed from trial com-
pletion, with small chances of the trial finally getting published.
Fig 1. Flowdiagram of the study selection.
https://doi.org/10.1371/journal.pone.0182785.g001
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Discussion
Summary of evidence
The present study assessed the publication fate as well as the completion-to-publication time
of all randomized trials in orthodontics that had been registered in ClinicalTrials.gov and
ISRCTN and had been filed as ‘completed’ up to January 2017.
The results indicated that at the time of completion of the present study (January 2017)
59% of all registered and completed trials had not been published, which corresponded to at
least 2355 included patients (some trials did not report the planned patient sample). This
agrees with similar studies on the biomedical literature that report non-publication rates of
29% [15], 34% [16], 50% [17], and 54% [14].
As far as time to publication is concerned, the results indicated that the median comple-
tion-to-publication time was 20.1 months (1.6 years). This also is similar to the findings of pre-
vious investigations, which report a median completion-to-publication time of 28.8 months
(2.4 years) [22]. Additionally, survival analysis indicated that most of the trials were published
Table 1. Demographics of the included registered trial protocols.
Na N %
Register ClinicalTrials.gov 80 45 56%
ISRCTN 35 44%
Country Austria 80 1 1%
Belgium 1 1%
Brazil 5 6%
Canada 2 3%
China 1 1%
Colombia 1 1%
Egypt 1 1%
France 2 3%
Germany 4 5%
Hong Kong 1 1%
India 3 4%
Iran 1 1%
Italy 2 3%
Kuwait 1 1%
Sweden 1 1%
Syria 4 5%
United Kingdom 35 44%
Uinted States of America 12 15%
Not reported 2 3%
Setting University 80 63 79%
Private 1 1%
Hospital 16 20%
Continent Europe 80 47 59%
Asia 11 14%
North America 14 18%
South America & Africa 8 10%
ISRCTN = International Standard Randomised Controlled Trial Number; Na = eligible trials trials included in
the assessment of this factor; N = trials in each factor category.
https://doi.org/10.1371/journal.pone.0182785.t001
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Table 2. Characteristics of the included registered trial protocols (binary variables).
Factor Category Na N %
Sponsor Internal 80 40 50%
Government 21 26%
Commercial 10 13%
Other 9 11%
Registration Prospective 80 19 24%
Retrospective 61 76%
Outcome Patient-reported 79 6 8%
Investigator-asserted 73 92%
Large trial (100 patients per trial arm) Yes 71 5 7%
No 66 93%
Multicenter trial Yes 80 6 8%
No 74 93%
Eligible patients Children 80 29 36%
Adults 8 10%
Mixed 29 36%
Not specified 14 18%
Trial published Yes 80 33 41%
No 47 59%
Publication fate after trial completion Within 12 months 33 10 30%
Within 24 months 18 55%
Within 36 months 27 82%
Within 48 months 29 88%
Within 60 months 30 91%
Publications from registered trial protocol None 80 47 59%
One 25 31%
Two 5 6%
Three 3 4%
Trials remaining unpublished after 5 years Yes 80 22 28%
No 58 72%
Journal Am J Orthod Dentofacial Orthop 33 8 24%
Angle Orthod 1 3%
Br J Oral Maxillofac Surg 1 3%
Caries Res 1 3%
Eur J Orthod 6 18%
Int J Paediatr Dent 1 3%
J Am Dent Assoc 1 3%
J Clin Diagn Res 1 3%
J Contemp Dent Pract 1 3%
J Dent Res 3 9%
J Indian Orthod Soc 1 3%
J Orthod 5 15%
J Pharm Biomed Sci 1 3%
Photomed Laser Surg 1 3%
Sci Rep 1 3%
Journal type Specialty (orthodontic) 33 21 64%
Non-specialty 12 36%
Journal with E-publication ahead of print Yes 33 18 55%
(Continued )
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within the first 24–48 months (2–4 years) after the trial’s completion. After about 60 months
(5 years) the trial publication rate was minimal, with only 3 trials (9% of all published trials)
being published this time point. This is similar to the results of Chapman et al. [16] that indi-
cated that the majority of published trials (73%) gets published within 48 months after trial
completion. This seems to also agree with Livas et al. [23] reporting that only half of study
abstracts presented in orthodontic congresses (therefore pertaining to completed studies)
Table 2. (Continued)
Factor Category Na N %
No 15 45%
Trial results Positive 33 15 42%
Not positive 14 45%
Unclear 4 12%
Na = eligible trials trials included in the assessment of this factor; N = trials in each factor category.
https://doi.org/10.1371/journal.pone.0182785.t002
Table 3. Cross-tabulation of subsequent trial publication and protocol characteristics.
Factor Category Published
N (%)
Unpublished
N (%)
P*
Registry ClinicalTrials.gov 20 (44%) 25 (56%) 0.51
ISRCTN 13 (37%) 22 (63%)
Sponsor Internal 14 (35%) 26 (65%) 0.30
Government 10 (48%) 11 (52%)
Commercial 3 (30%) 7 (70%)
Other 6 (67%) 3 (33%)
Affiliation University 26 (41%) 37 (59%) 1.00
Private practice 0 (0%) 1 (100%)
Hospital 7 (78%) 9 (22%)
Continent Europe 20 (43%) 27 (57%) 0.30
Asia 8 (73%) 3 (27%)
N. America 2 (14%) 12 (86%)
S. America & Africa 3 (38%) 5 (62%)
Registration Prospectively 26 (43%) 35 (57%) 0.66
Retrospectively 7 (37%) 12 (63%)
Outcome Patient-reported 31 (42%) 42 (58%) 1.00
Doctor-assessed 2 (33%) 4 (67%)
Multicenter trial Yes 2 (33%) 4 (67%) 1.00
No 31 (42%) 42 (58%)
Patients Children 14 (48%) 15 (52%) 0.07
Adults 2 (25%) 6 (75%)
Mixed 15 (52%) 14 (48%)
Not specified 2 (14%) 12 (86%)
Large trial Yes 4 (80%) 1 (20%) 0.17
No 28 (42%) 38 (58%)
ISRCTN = International Standard Randomised Controlled Trial Number.
*from chi-square (or Fisher’s exact test, when more than 20% of the cells have expected frequency less than five or at least one is null)
https://doi.org/10.1371/journal.pone.0182785.t003
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reach full publication, with a median presentation-to-publication time of 16 months (1.3
years).
Several registry-, trial-, or patient-related characteristics seemed to affect the publication
fate of included registered trials, as seen through the Kaplan-Meier survival estimates and the
log-rank tests (Table D in S1 File; Figures B-M in S2 File). For one, considerable differences
were observed between trials registered in ClinicalTrials.gov and those registered in ISRCTN,
with trials registered in the latter being published less often and later. This might indicate that
a true difference exists in the publication of completed trials, but it might also be associated
with the considerable geographic differences in the content of the two registries, as ISRCTN
included trials primarily from the United Kingdom, while ClinicalTrials.gov had a wider con-
tribution spectrum (Figure N in S2 File).
Counting only unpublished trials with a follow-up period of more than 5 years after trial
completion to allow for a free period to be published, indicated that 28% (n = 22) of identified
trials still remained unpublished. This is of importance as, based on present results, the chance
of those trials being eventually published is small. This represents a waste of resources as well
as a gap in the existing research evidence in orthodontics that can have a direct impact on sys-
tematic reviews of clinical trials and subsequently on clinical decision making. For example,
several trials on new appliances or novel adjunct procedures aimed to expedite orthodontic
treatment remain for the present unpublished (Table E in S1 File), which means that existing
systematic reviews on this subject [24–27] might not reflect the actual evidence base.
There are several steps that could be implemented toward improvement of trial registration
and trial publication practices. Agencies funding clinical trials could implement stricter sur-
veillance systems for trial publication fate and urge researchers to publish the results of their
trials, no matter how positive or negative these might seem. Authors are encouraged to register
trials prior to trial initiation. In the present study, the majority (76%) of randomized trials
were registered retrospectively, something that has also been seen in other fields of medicine
[20], but does neither correspond to the notion of a priori trial registration nor does it safe-
guard against selective reporting. Editors of orthodontic journals should avoid judging trial
submissions from the attractiveness of their findings and should pursue publication of trials
with negative results. Furthermore, editors can indirectly promote trial registration by using it
as a prerequisite for a trial to be considered for publication in the journals they manage. The
ICMJE changed policy in 2005 to adopt this [7], which resulted in an increase of trial registra-
tion [8]. This requirement was later incorporated into the ICMJE’s “uniform requirements for
manuscripts submitted to biomedical journals,” along with the updated CONSORT 2010 state-
ment for the reporting of randomized controlled trials [28]. Even though a large part of medi-
cal journals requires trials to be registered [29], the landscape in orthodontics still remains
bleak: although half (5 out of 10) of orthodontic journals mention registration of randomized
clinical trials at their ‘Instructions for authors’ websites, only one (Journal of Orthodontics)
words this explicitly as a requirement for publication.
Table 4. Characteristics of the included registered trial protocols (continuous variables).
Outcome Extracted from Na Mean (SD) Median (IQR) Range
Reported sample size (patients) Protocol 71 87.2 (138.4) 50.0 (30.0–90.0) 8.0–1000.0
Trial duration (months) Protocol 80 29.5 (22.4) 24.3 (15.2–36.5) 0.9–124.8
Completion-to-publication (months) Protocol / publication 33 24.5 (18.0) 20.1 (9.1–31.6) 1.8–65.0
Mean follow-up of trial protocol for the present study (months) Protocol / publication 80 47.7 (45.8) 28.4 (13.0–64.7) 1.8–166.6
SD = standard deviation; IQR = interquartile range (Q1-Q3).
https://doi.org/10.1371/journal.pone.0182785.t004
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Strengths and limitations
The strengths of the present study include its comprehensive search of all registered random-
ized trials in orthodontics and their subsequent publications, as well as the duplicate study
selection and data extraction procedures from two independent authors. However, several lim-
itations exist, with first and foremost being the limited number of available registered and
completed trials in orthodontics, which affects the study’s statistical power and together with
the high number of statistical tests potentially inflates the risk of false findings. Secondly, the
present study is dependent upon the reporting quality of the registered trial protocols, which
was not always perfect and might even not necessarily reflect the reality. Additionally, although
the time from trial completion to publication was based on previously-used date extraction
methodology, it is an indirect and possibly imprecise measurement, which does not necessarily
agree to a direct follow-up of the trial procedures. Also, the cut-off of 100 patients per trial arm
used to categorize trials as large or not large is arbitrary and is not based on a case by case
assessment of each outcome, but rather on previous empirical data from general medicine.
Finally, we do not know if published trials were previously rejected from any other journals
prior to their final publication, which might lead to increased completion-to-publication
times.
Conclusions
The present study within its limitations indicates that around 40% of completed registered ran-
domized trials in orthodontics remains unpublished, while the majority of trials get published
in the first 24 to 48 months after completion. However, around one third (28%) of identified
completed randomized trials in orthodontics remained unpublished even 5 years after their
completion, which could be associated with gaps in the modus operandi of orthodontics
research and should be taken into account when evaluating the existing orthodontic research.
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